Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cara Therapeutics, Inc. (CARA)

« Back to company index

CARA Chatter Timeline

Stock Ticker for CARA

Most Active Tweeters for CARA

UserTweets
@Tickeron 10
@dailypoliticaln 4
@BlueBioNow 4
@AmericanBanking 4
@ZolmaxNews 4

Recent Tweets for CARA

Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/YfK4gMHsge
October 21st 2019, 8:10pm
gcassidy718 @gcassidy718
$CARA Wow. Printing money ???????????????? 2.04 % change recently https://t.co/vZLeec0p8k
October 21st 2019, 5:10pm
BlueBioNow @BlueBioNow
$CARA Valuation is starting to make more sense now $17.22. https://t.co/mmkUnqqUKF
October 21st 2019, 10:10am
TranscriptDaily @TranscriptDaily
Needham & Company LLC Reaffirms Buy Rating for Cara Therapeutics $CARA https://t.co/CQPKvmwisU
October 21st 2019, 6:10am
TickerReport @TickerReport
Cara Therapeutics Inc $CARA Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/v9gItgjOZs
October 21st 2019, 3:10am
dailypoliticaln @dailypoliticaln
Cara Therapeutics Inc $CARA Given Consensus Recommendation of “Buy” by Analysts https://t.co/la9p3qFQxq
October 21st 2019, 3:10am
Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/fq1aeo4f3a
October 20th 2019, 8:10pm
ThisLincolnian @ThisLincolnian
Cara Therapeutics’ $CARA Buy Rating Reiterated at Needham & Company LLC https://t.co/cBD0yY51pP
October 20th 2019, 10:10am
BlueBioNow @BlueBioNow
$CARA definitely going to finish under $17.22 -2.84 % change recently https://t.co/mmkUnqqUKF
October 20th 2019, 8:10am
Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/5uCOnBk1lM
October 19th 2019, 11:10pm
dakotafinancial @dakotafinancial
Cara Therapeutics $CARA Given Buy Rating at Needham & Company LLC https://t.co/0yk694ExFC
October 19th 2019, 9:10am
Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/6eOjvSvDC1
October 19th 2019, 1:10am
dispatchtribune @dispatchtribune
Cara Therapeutics $CARA Given “Buy” Rating at Needham & Company LLC https://t.co/bL3WAVSfVR
October 18th 2019, 5:10pm
OlympiaReport @OlympiaReport
Cara Therapeutics $CARA Earns “Buy” Rating from Needham & Company LLC https://t.co/VyhQ7114U7
October 18th 2019, 5:10pm
TheMarketsDaily @TheMarketsDaily
Insider Selling: Cara Therapeutics Inc $CARA SVP Sells 4,000 Shares of Stock https://t.co/Wj2Mof0qYK
October 18th 2019, 5:10am
macondailynews @macondailynews
Frederique Ph.D. Menzaghi Sells 4,000 Shares of Cara Therapeutics Inc $CARA Stock https://t.co/DhTu9ChDsI
October 18th 2019, 5:10am
Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/vlTUpseNVb
October 17th 2019, 9:10pm
AmericanBanking @AmericanBanking
Cara Therapeutics $CARA Given Buy Rating at Needham & Company LLC https://t.co/iPFqfEmkQ9 #stocks
October 17th 2019, 7:10am
ConsumerFeed @ConsumerFeed
Cara Therapeutics’ $CARA Buy Rating Reaffirmed at Needham & Company LLC https://t.co/bxWdgydbtw
October 17th 2019, 7:10am
HempNews1 @HempNews1
Needham Remains a Buy on Cara Therapeutics (CARA) $CARA #cara https://t.co/SwiyE2mCce
October 17th 2019, 7:10am
WeekHerald @WeekHerald
Cara Therapeutics Inc $CARA SVP Frederique Ph.D. Menzaghi Sells 4,000 Shares of Stock https://t.co/0xaV5DRMAd
October 17th 2019, 6:10am
ThisLincolnian @ThisLincolnian
Frederique Ph.D. Menzaghi Sells 4,000 Shares of Cara Therapeutics Inc $CARA Stock https://t.co/QfJtNDjH3l
October 17th 2019, 6:10am
Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/S7C6x3qeDO
October 16th 2019, 9:10pm
ZolmaxNews @ZolmaxNews
Cara Therapeutics Inc $CARA SVP Sells $74,800.00 in Stock https://t.co/oVDDzGxsY8
October 16th 2019, 9:10pm
AmericanBanking @AmericanBanking
Insider Selling: Cara Therapeutics Inc $CARA SVP Sells 4,000 Shares of Stock https://t.co/M1YO1XUzGT #stocks
October 16th 2019, 9:10pm
dailypoliticaln @dailypoliticaln
Insider Selling: Cara Therapeutics Inc $CARA SVP Sells 4,000 Shares of Stock https://t.co/0AhRmMkRNQ
October 16th 2019, 9:10pm
InsiderAlertsIA @InsiderAlertsIA
$CARA: New Insider Filing on Chief Scientific Off,SVP-R&D FREDERIQUE PH.D. MENZAGHI: https://t.co/hn2khyyAKd
October 16th 2019, 6:10pm
fintel_io @fintel_io
Insider Menzaghi Frederique Ph.D. reports selling 4,000 shares of $CARA for a total cost of $74,800.00 [CLICK FOR… https://t.co/VIRPIyxHjS
October 16th 2019, 6:10pm
confcalltran @confcalltran
Chief Scientific Off of Cara Therapeutics just disposed of 4,000 shares https://t.co/NQccNoKy8z $CARA
October 16th 2019, 6:10pm
WatchlistN @WatchlistN
Short Interest in Cara Therapeutics Inc $CARA Drops By 5.3% https://t.co/E0eH2k0aip
October 16th 2019, 4:10am
AmericanBanking @AmericanBanking
Short Interest in Cara Therapeutics Inc $CARA Drops By 5.3% https://t.co/W3QkEBpwIJ #stocks
October 16th 2019, 4:10am
Tickeron @Tickeron
$CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/Pc25go8lJ6
October 15th 2019, 9:10pm
BlueBioNow @BlueBioNow
$CARA Do we see $21.46 next?  3.45 % change recently https://t.co/mmkUnqqUKF
October 15th 2019, 7:10pm
sweetbabyfazool @sweetbabyfazool
$cara data coming in Q4 - then the moon - ez double in 2020
October 15th 2019, 11:10am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $CARA for you: -23.25% https://t.co/VVRkDJueNx
October 15th 2019, 4:10am
HempNews1 @HempNews1
Cara Delevingne says she's the 'luckiest girl' $CARA #cara https://t.co/eeSxWYzh6R
October 15th 2019, 4:10am
Tickeron @Tickeron
$CARA in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 20, 2019. View odds for… https://t.co/Dz4lK6abfc
October 14th 2019, 8:10pm
Quantumup1 @Quantumup1
$CARA kept at a Buy rating , $33 PT at Stifel https://t.co/U3GG0HKTAI
October 14th 2019, 11:10am
MaisaCorp @MaisaCorp
$CARA an independent data monitoring committee has recommended increasing the enrollment in the phase 3 trial of Ko… https://t.co/JDHQDdtF9e
October 14th 2019, 10:10am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $CARA is $-0.38 it's -2.02% of the current price https://t.co/cktmJAMXcN
October 14th 2019, 9:10am
AlertTrade @AlertTrade
RT @Briefingcom: $CARA: Cara Therapeutics reports patient enrollment for KALM-2 Phase 3 Global Trial of KORSUVA increased... https://t.co/b…
October 14th 2019, 9:10am
Briefingcom @Briefingcom
$CARA: Cara Therapeutics reports patient enrollment for KALM-2 Phase 3 Global Trial of KORSUVA increased... https://t.co/bnLSVKNSuQ
October 14th 2019, 9:10am
1MinuteStock @1MinuteStock
Wondering about risks of $CARA? The 21-day volatility is 13.75% https://t.co/9TkbXkrCmK
October 14th 2019, 9:10am
biostockinfo @biostockinfo
RT @BioStocks: $CARA Trial Size to Be Increased to 430 Patients From 350 to Maintain Pre-Specified Statistical Power of 90% or Greater on T…
October 14th 2019, 8:10am
newswelldone @newswelldone
$CARA: Cara to increase enrollment in second late-stage study of Korsuva in …: https://t.co/LYfM5WcO0K
October 14th 2019, 8:10am
AdmirableAtroc1 @AdmirableAtroc1
RT @MarijuanaStocks: $CARA Announces Completion of Interim Statistical Assessment #potstocks #mjstocks #stocks https://t.co/cBeTwRzyVs
October 14th 2019, 8:10am
MarijuanaStocks @MarijuanaStocks
$CARA Announces Completion of Interim Statistical Assessment #potstocks #mjstocks #stocks https://t.co/cBeTwRzyVs
October 14th 2019, 8:10am
tabuhasna @tabuhasna
Cara to increase enrollment in second late-stage study of Korsuva in CKD-aP $CARA https://t.co/dITrszjMwx
October 14th 2019, 7:10am
MarketCurrents @MarketCurrents
$CARA - Cara to increase enrollment in late-stage study of Korsuva in CKD-aP https://t.co/54sl5LAQPG
October 14th 2019, 7:10am
ToothFrank @ToothFrank
$CARA Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Pha… https://t.co/FHYNJtTDbI
October 14th 2019, 7:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.